Form 8-K MCKESSON CORP For: Sep 05
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St declines as oil spikes after Trump rejects Iran peace proposal
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Bloom Energy shares fall on Oracle project halt
- Oppenheimer sees AI software winners as focus shifts to ROI
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Accenture (ACN) call put ratio 1 call to 1.2 puts into quarter results
- Arm Holdings falls as CFO stock sale weighs on sentiment
McKesson (MCK) PT Lowered to $665 at Leerink Partners
September 6, 2024 6:36 AM EDTLeerink Partners analyst Michael Cherny lowered the price target on McKesson (NYSE: MCK) to $665.00 (from $670.00) while maintaining a Outperform rating.
The analyst comments "Bottom Line: Since last earnings, MCK has certainly muddied the waters for what had primarily been a straightforward beat-and-raise story. The... More
McKesson (MCK) Declines After Issuing Soft Second Quarter EPS Guidance
September 5, 2024 12:08 PM EDT(Updated - September 5, 2024 12:08 PM EDT)
McKesson (NYSE: MCK) disclosed:
McKesson Corporation participated in the Wells Fargo 2024 Healthcare Conference on September 5, 2024, as previously noticed in the companys August 7, 2024 earnings release and on its investor relations website investor.mckesson.com.
During the... More
